Myasthenia Gravis

Drug Name: Rystiggo Indications: To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor- or anti-muscle-specific tyrosine kinase antibody-positive. Active Ingredient: Rozanolixizumab-noli Company: UCB, Inc Approval Date: 6/26/2023 More…